YDES (YD Bio) Other Current Payables: $0.79 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YDES YD Bio Ltd YDES
12 GF Score
Price $2.30
! 1 Warning Sign
View Full Analysis

What is YD Bio Other Current Payables?

YD Bio YDES +9.80% 12 Other Current Payables is $0.79 Mil as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

YD Bio's Other Current Payables for the quarter that ended in Dec. 2025 was $0.79 Mil.

YD Bio's quarterly Other Current Payables declined from Dec. 2024 ($0.04 Mil) to Jun. 2025 ($0.04 Mil) but then increased from Jun. 2025 ($0.04 Mil) to Dec. 2025 ($0.79 Mil).

YD Bio's annual Other Current Payables increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.04 Mil) and increased from Dec. 2024 ($0.04 Mil) to Dec. 2025 ($0.79 Mil).

YD Bio Other Current Payables Related Terms

YD Bio Other Current Payables Historical Data

* Premium members only.

The historical data trend for YD Bio's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YD Bio Other Current Payables Chart

YD Bio Annual Data
Trend Dec23 Dec24 Dec25
Other Current Payables
0.00 0.04 0.79

YD Bio Semi-Annual Data
Dec24 Jun25 Dec25
Other Current Payables 0.04 0.04 0.79
YDES
12GF Score
YD Bio Ltd YDES
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

YD Bio Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.79 Mil mean?
YD Bio (YDES) has a Other Current Payables of $0.79 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on YD Bio and its competitors.
Is YD Bio's Other Current Payables too high?
YD Bio's current Other Current Payables is $0.79 Mil. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's Other Current Payables compare to ALEC and CAMP?
YD Bio's Other Current Payables of $0.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on YD Bio and its competitors. YD Bio's current Other Current Payables is $0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current Other Current Payables of $0.79 Mil. The current Other Current Payables is $0.79 Mil. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For YD Bio (YDES), the current Other Current Payables is $0.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

YD Bio Business Description

Address No. 3, Xingnan Street, 12th Floor, Nangang District, Taipei City, TWN, 115001
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score

Get the complete analysis for YDES

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.30
Price